世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および米国の早発卵巣不全治療薬市場規模、現状、予測 2021-2028年

世界および米国の早発卵巣不全治療薬市場規模、現状、予測 2021-2028年


Global and United States Premature Ovarian Failure Cure Market Size, Status and Forecast 2021-2028

市場分析と洞察。世界と米国の早発性卵巣不全治療薬市場 本レポートは、世界と米国の早発卵巣不全治療薬市場に焦点を当て、その他の地域の地域レベル、郡レベルのセグメントデータもカバーしています。 COVID-1... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2022年4月14日 US$4,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析と洞察。世界と米国の早発性卵巣不全治療薬市場
本レポートは、世界と米国の早発卵巣不全治療薬市場に焦点を当て、その他の地域の地域レベル、郡レベルのセグメントデータもカバーしています。
COVID-19の流行により、世界の早発卵巣不全治療薬市場規模は2022年に9億5499万米ドル相当と推定され、レビュー期間中にCAGR7.62％で2028年までに14億8397万米ドルに再調整されると予測されています。
米国では、早発卵巣不全治療薬の市場規模は2022年の3億8702万米ドルから2028年には5億3876万米ドルに成長し、予測期間中のCAGRは5.67%と予測されています。

世界の早発性卵巣不全治療薬の範囲と市場規模
早発性卵巣不全治療薬市場は、地域および国レベル、プレイヤー別、タイプ別、用途別に区分されています。世界の早発卵巣不全治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の収益と予測に焦点を当てます。
米国市場については、2017-2028年までのプレイヤー別、タイプ別、アプリケーション別の早発卵巣不全治療薬市場規模に焦点を当てます。主要プレイヤーには、米国で重要な役割を果たすグローバルプレイヤーおよびローカルプレイヤーが含まれます。

企業別
ファイザー
バイエル
ノバルティス
バイオサイエンス研究所
ジョンズ・ホプキンス医学研究所
メイヨークリニック
バプティスト・ヘルス
インディラIVF

種類別セグメント
ホルモン補充療法(HRT)
カルシウム・ビタミンDサプリメント
体外受精(IVF)
幹細胞治療
その他

用途別セグメント
20歳未満
20歳以上30歳未満
30歳以上45歳未満
45歳以上

地域別
北アメリカ
米国
カナダ

アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア

欧州
ドイツ
フランス
イギリス
イタリア
ロシア

中南米
メキシコ
ブラジル

中東・アフリカ
サウジアラビア
UAE
エジプト
南アフリカ共和国


ページTOPに戻る


目次

1 STUDY COVERAGE 1
1.1 Premature Ovarian Failure Cure Product Introduction 1
1.2 Global Premature Ovarian Failure Cure Outlook, 2017 VS 2022 VS 2028 2
1.2.1 Global Premature Ovarian Failure Cure Market Size for the Year 2017-2028 2
1.2.2 United States Premature Ovarian Failure Cure Market Size for the Year 2017-2028 4
1.3 Premature Ovarian Failure Cure Market Size, United States VS Global, 2017 VS 2022 VS 2028 6
1.3.1 The Market Share of United States Premature Ovarian Failure Cure in Global, 2017 VS 2022 VS 2028 6
1.3.2 The Growth Rate of Premature Ovarian Failure Cure Market Size, United States VS Global, 2017 VS 2022 VS 2028 6
1.4 Premature Ovarian Failure Cure Market Dynamics 7
1.4.1 Premature Ovarian Failure Cure Industry Trends 7
1.4.2 Premature Ovarian Failure Cure Market Drivers 7
1.4.3 Premature Ovarian Failure Cure Market Challenges 8
1.4.4 Premature Ovarian Failure Cure Market Restraints 9
1.5 Study Objectives 9
1.6 Years Considered 10
2 PREMATURE OVARIAN FAILURE CURE BY TYPE 11
2.1 Premature Ovarian Failure Cure Market Segment by Type 11
2.1.1 Hormone Replacement Therapy (HRT) 11
2.1.2 Calcium and Vitamin D Supplements 11
2.1.3 In Vitro Fertilization (IVF) 11
2.1.4 Stem Cell Therapy 12
2.1.5 Others 13
2.2 Global Premature Ovarian Failure Cure Market Size by Type (2017, 2022 & 2028) 13
2.3 Global Premature Ovarian Failure Cure Market Size by Type (2017-2028) 15
2.4 United States Premature Ovarian Failure Cure Market Size by Type (2017, 2022 & 2028) 16
2.5 United States Premature Ovarian Failure Cure Market Size by Type (2017-2028) 18
3 PREMATURE OVARIAN FAILURE CURE BY APPLICATION 19
3.1 Premature Ovarian Failure Cure Market Segment by Application 19
3.1.1 Less than 20 Years Old 19
3.1.2 20 to 30 Years Old 19
3.1.3 30 to 45 Years Old 19
3.1.4 45 Years Old and Older 19
3.2 Global Premature Ovarian Failure Cure Market Size, by Application (2017, 2022 & 2028) 20
3.3 Global Premature Ovarian Failure Cure Market Size by Application (2017-2028) 22
3.4 United States Premature Ovarian Failure Cure Market Size by Application (2017, 2022 & 2028) 23
3.5 United States Premature Ovarian Failure Cure Market Size by Application (2017-2028) 25
4 GLOBAL PREMATURE OVARIAN FAILURE CURE COMPETITOR LANDSCAPE BY COMPANY 26
4.1 Global Premature Ovarian Failure Cure Market Size by Company 26
4.1.1 Top Global Premature Ovarian Failure Cure Companies Ranked by Revenue (2021) 26
4.1.2 Global Premature Ovarian Failure Cure Revenue by Player (2017-2022) 26
4.2 Global Premature Ovarian Failure Cure Concentration Ratio (CR) 27
4.2.1 Premature Ovarian Failure Cure Market Concentration Ratio (CR) (2017-2022) 27
4.2.2 Global Top 3 and Top 5 Largest Companies of Premature Ovarian Failure Cure in 2021 29
4.2.3 Global Premature Ovarian Failure Cure Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 29
4.3 Global Premature Ovarian Failure Cure Headquarters, Product Type 30
4.3.1 Global Premature Ovarian Failure Cure Headquarters and Area Served 30
4.3.2 Global Premature Ovarian Failure Cure Companies Product Type 31
4.3.3 Date of International Companies Enter into Premature Ovarian Failure Cure Market 31
4.4 Companies Mergers & Acquisitions, Expansion Plans 32
4.5 United States Premature Ovarian Failure Cure Market Size by Company 32
4.5.1 Top Premature Ovarian Failure Cure Players in United States, Ranked by Revenue (2021) 32
4.5.2 United States Premature Ovarian Failure Cure Revenue by Players (2020, 2021 & 2022) 33
5 GLOBAL PREMATURE OVARIAN FAILURE CURE MARKET SIZE BY REGION 34
5.1 Global Premature Ovarian Failure Cure Market Size by Region: 2017 VS 2022 VS 2028 34
5.2 Global Premature Ovarian Failure Cure Market Size by Region (2017-2028) 36
5.2.1 Global Premature Ovarian Failure Cure Market Size by Region: 2017-2022 36
5.2.2 Global Premature Ovarian Failure Cure Market Size by Region: 2023-2028 37
6 SEGMENT IN REGIONAL LEVEL & COUNTRY LEVEL 38
6.1 North America 38
6.1.1 North America Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 38
6.1.2 North America Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 38
6.1.3 United States 39
6.1.4 Canada 39
6.2 Europe 40
6.2.1 Europe Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 40
6.2.2 Europe Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 40
6.2.3 Germany 41
6.2.4 France 41
6.2.5 U.K. 42
6.2.6 Italy 42
6.2.7 Russia 43
6.3 Asia-Pacific 44
6.3.1 Asia-Pacific Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 44
6.3.2 Asia-Pacific Premature Ovarian Failure Cure Market Facts & Figures by Region (2017, 2022 & 2028) 44
6.3.3 China 45
6.3.4 Japan 45
6.3.5 South Korea 46
6.3.6 Southeast Asia 46
6.3.7 India 47
6.3.8 Australia 47
6.4 Latin America 48
6.4.1 Latin America Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 48
6.4.2 Latin America Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 48
6.4.3 Mexico 49
6.4.4 Brazil 49
6.5 Middle East and Africa 50
6.5.1 Middle East and Africa Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 50
6.5.2 Middle East and Africa Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 50
6.5.3 Saudi Arabia 51
6.5.4 UAE 51
6.5.5 Egypt 52
6.5.6 South Africa 52
7 KEY PLAYERS PROFILES 53
7.1 Pfizer 53
7.1.1 Pfizer Company Details 53
7.1.2 Pfizer Business Overview 53
7.1.3 Pfizer Premature Ovarian Failure Cure Introduction 54
7.1.4 Pfizer Revenue in Premature Ovarian Failure Cure Business (2017-2022) 55
7.1.5 Pfizer Recent Development 55
7.2 Bayer 56
7.2.1 Bayer Company Details 56
7.2.2 Bayer Business Overview 56
7.2.3 Bayer Premature Ovarian Failure Cure Introduction 57
7.2.4 Bayer Revenue in Premature Ovarian Failure Cure Business (2017-2022) 57
7.2.5 Bayer Recent Development 57
7.3 Novartis 58
7.3.1 Novartis Company Details 58
7.3.2 Novartis Business Overview 58
7.3.3 Novartis Premature Ovarian Failure Cure Introduction 59
7.3.4 Novartis Revenue in Premature Ovarian Failure Cure Business (2017-2022) 60
7.3.5 Novartis Recent Development 60
7.4 Bioscience Institute 60
7.4.1 Bioscience Institute Company Details 60
7.4.2 Bioscience Institute Business Overview 61
7.4.3 Bioscience Institute Premature Ovarian Failure Cure Introduction 61
7.4.4 Bioscience Institute Revenue in Premature Ovarian Failure Cure Business (2017-2022) 62
7.4.5 Bioscience Institute Recent Development 62
7.5 Johns Hopkins Medicine 62
7.5.1 Johns Hopkins Medicine Company Details 62
7.5.2 Johns Hopkins Medicine Business Overview 63
7.5.3 Johns Hopkins Medicine Premature Ovarian Failure Cure Introduction 63
7.5.4 Johns Hopkins Medicine Revenue in Premature Ovarian Failure Cure Business (2017-2022) 64
7.5.5 Johns Hopkins Medicine Recent Development 64
7.6 Mayo Clinic 64
7.6.1 Mayo Clinic Company Details 64
7.6.2 Mayo Clinic Business Overview 65
7.6.3 Mayo Clinic Premature Ovarian Failure Cure Introduction 65
7.6.4 Mayo Clinic Revenue in Premature Ovarian Failure Cure Business (2017-2022) 66
7.6.5 Mayo Clinic Recent Development 66
7.7 Baptist Health 67
7.7.1 Baptist Health Company Details 67
7.7.2 Baptist Health Business Overview 67
7.7.3 Baptist Health Premature Ovarian Failure Cure Introduction 68
7.7.4 Baptist Health Revenue in Premature Ovarian Failure Cure Business (2017-2022) 68
7.7.5 Baptist Health Recent Development 69
7.8 Indira IVF 69
7.8.1 Indira IVF Company Details 69
7.8.2 Indira IVF Business Overview 69
7.8.3 Indira IVF Premature Ovarian Failure Cure Introduction 70
7.8.4 Indira IVF Revenue in Premature Ovarian Failure Cure Business (2017-2022) 71
7.8.5 Indira IVF Recent Development 71
8 RESEARCH FINDINGS AND CONCLUSION 72
9 APPENDIX 74
9.1 Research Methodology 74
9.1.1 Methodology/Research Approach 74
9.1.2 Data Source 77
9.2 Disclaimer 80
9.3 Author Details 80

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global and United States Premature Ovarian Failure Cure Market
This report focuses on global and United States Premature Ovarian Failure Cure market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Premature Ovarian Failure Cure market size is estimated to be worth US$ 954.99 million in 2022 and is forecast to a readjusted size of US$ 1,483.97 million by 2028 with a CAGR of 7.62% during the review period.
In United States the Premature Ovarian Failure Cure market size is expected to grow from US$ 387.02 million in 2022 to US$ 538.76 million by 2028, at a CAGR of 5.67% during the forecast period.

Global Premature Ovarian Failure Cure Scope and Market Size
Premature Ovarian Failure Cure market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Premature Ovarian Failure Cure market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Premature Ovarian Failure Cure market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in United States.

By Company
Pfizer
Bayer
Novartis
Bioscience Institute
Johns Hopkins Medicine
Mayo Clinic
Baptist Health
Indira IVF

Segment by Type
Hormone Replacement Therapy (HRT)
Calcium and Vitamin D Supplements
In Vitro Fertilization (IVF)
Stem Cell Therapy
Others

Segment by Application
Less than 20 Years Old
20 to 30 Years Old
30 to 45 Years Old
45 Years Old and Older

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil

Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa



ページTOPに戻る


Table of Contents

1 STUDY COVERAGE 1
1.1 Premature Ovarian Failure Cure Product Introduction 1
1.2 Global Premature Ovarian Failure Cure Outlook, 2017 VS 2022 VS 2028 2
1.2.1 Global Premature Ovarian Failure Cure Market Size for the Year 2017-2028 2
1.2.2 United States Premature Ovarian Failure Cure Market Size for the Year 2017-2028 4
1.3 Premature Ovarian Failure Cure Market Size, United States VS Global, 2017 VS 2022 VS 2028 6
1.3.1 The Market Share of United States Premature Ovarian Failure Cure in Global, 2017 VS 2022 VS 2028 6
1.3.2 The Growth Rate of Premature Ovarian Failure Cure Market Size, United States VS Global, 2017 VS 2022 VS 2028 6
1.4 Premature Ovarian Failure Cure Market Dynamics 7
1.4.1 Premature Ovarian Failure Cure Industry Trends 7
1.4.2 Premature Ovarian Failure Cure Market Drivers 7
1.4.3 Premature Ovarian Failure Cure Market Challenges 8
1.4.4 Premature Ovarian Failure Cure Market Restraints 9
1.5 Study Objectives 9
1.6 Years Considered 10
2 PREMATURE OVARIAN FAILURE CURE BY TYPE 11
2.1 Premature Ovarian Failure Cure Market Segment by Type 11
2.1.1 Hormone Replacement Therapy (HRT) 11
2.1.2 Calcium and Vitamin D Supplements 11
2.1.3 In Vitro Fertilization (IVF) 11
2.1.4 Stem Cell Therapy 12
2.1.5 Others 13
2.2 Global Premature Ovarian Failure Cure Market Size by Type (2017, 2022 & 2028) 13
2.3 Global Premature Ovarian Failure Cure Market Size by Type (2017-2028) 15
2.4 United States Premature Ovarian Failure Cure Market Size by Type (2017, 2022 & 2028) 16
2.5 United States Premature Ovarian Failure Cure Market Size by Type (2017-2028) 18
3 PREMATURE OVARIAN FAILURE CURE BY APPLICATION 19
3.1 Premature Ovarian Failure Cure Market Segment by Application 19
3.1.1 Less than 20 Years Old 19
3.1.2 20 to 30 Years Old 19
3.1.3 30 to 45 Years Old 19
3.1.4 45 Years Old and Older 19
3.2 Global Premature Ovarian Failure Cure Market Size, by Application (2017, 2022 & 2028) 20
3.3 Global Premature Ovarian Failure Cure Market Size by Application (2017-2028) 22
3.4 United States Premature Ovarian Failure Cure Market Size by Application (2017, 2022 & 2028) 23
3.5 United States Premature Ovarian Failure Cure Market Size by Application (2017-2028) 25
4 GLOBAL PREMATURE OVARIAN FAILURE CURE COMPETITOR LANDSCAPE BY COMPANY 26
4.1 Global Premature Ovarian Failure Cure Market Size by Company 26
4.1.1 Top Global Premature Ovarian Failure Cure Companies Ranked by Revenue (2021) 26
4.1.2 Global Premature Ovarian Failure Cure Revenue by Player (2017-2022) 26
4.2 Global Premature Ovarian Failure Cure Concentration Ratio (CR) 27
4.2.1 Premature Ovarian Failure Cure Market Concentration Ratio (CR) (2017-2022) 27
4.2.2 Global Top 3 and Top 5 Largest Companies of Premature Ovarian Failure Cure in 2021 29
4.2.3 Global Premature Ovarian Failure Cure Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 29
4.3 Global Premature Ovarian Failure Cure Headquarters, Product Type 30
4.3.1 Global Premature Ovarian Failure Cure Headquarters and Area Served 30
4.3.2 Global Premature Ovarian Failure Cure Companies Product Type 31
4.3.3 Date of International Companies Enter into Premature Ovarian Failure Cure Market 31
4.4 Companies Mergers & Acquisitions, Expansion Plans 32
4.5 United States Premature Ovarian Failure Cure Market Size by Company 32
4.5.1 Top Premature Ovarian Failure Cure Players in United States, Ranked by Revenue (2021) 32
4.5.2 United States Premature Ovarian Failure Cure Revenue by Players (2020, 2021 & 2022) 33
5 GLOBAL PREMATURE OVARIAN FAILURE CURE MARKET SIZE BY REGION 34
5.1 Global Premature Ovarian Failure Cure Market Size by Region: 2017 VS 2022 VS 2028 34
5.2 Global Premature Ovarian Failure Cure Market Size by Region (2017-2028) 36
5.2.1 Global Premature Ovarian Failure Cure Market Size by Region: 2017-2022 36
5.2.2 Global Premature Ovarian Failure Cure Market Size by Region: 2023-2028 37
6 SEGMENT IN REGIONAL LEVEL & COUNTRY LEVEL 38
6.1 North America 38
6.1.1 North America Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 38
6.1.2 North America Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 38
6.1.3 United States 39
6.1.4 Canada 39
6.2 Europe 40
6.2.1 Europe Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 40
6.2.2 Europe Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 40
6.2.3 Germany 41
6.2.4 France 41
6.2.5 U.K. 42
6.2.6 Italy 42
6.2.7 Russia 43
6.3 Asia-Pacific 44
6.3.1 Asia-Pacific Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 44
6.3.2 Asia-Pacific Premature Ovarian Failure Cure Market Facts & Figures by Region (2017, 2022 & 2028) 44
6.3.3 China 45
6.3.4 Japan 45
6.3.5 South Korea 46
6.3.6 Southeast Asia 46
6.3.7 India 47
6.3.8 Australia 47
6.4 Latin America 48
6.4.1 Latin America Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 48
6.4.2 Latin America Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 48
6.4.3 Mexico 49
6.4.4 Brazil 49
6.5 Middle East and Africa 50
6.5.1 Middle East and Africa Premature Ovarian Failure Cure Market Size YoY Growth 2017-2028 50
6.5.2 Middle East and Africa Premature Ovarian Failure Cure Market Facts & Figures by Country (2017, 2022 & 2028) 50
6.5.3 Saudi Arabia 51
6.5.4 UAE 51
6.5.5 Egypt 52
6.5.6 South Africa 52
7 KEY PLAYERS PROFILES 53
7.1 Pfizer 53
7.1.1 Pfizer Company Details 53
7.1.2 Pfizer Business Overview 53
7.1.3 Pfizer Premature Ovarian Failure Cure Introduction 54
7.1.4 Pfizer Revenue in Premature Ovarian Failure Cure Business (2017-2022) 55
7.1.5 Pfizer Recent Development 55
7.2 Bayer 56
7.2.1 Bayer Company Details 56
7.2.2 Bayer Business Overview 56
7.2.3 Bayer Premature Ovarian Failure Cure Introduction 57
7.2.4 Bayer Revenue in Premature Ovarian Failure Cure Business (2017-2022) 57
7.2.5 Bayer Recent Development 57
7.3 Novartis 58
7.3.1 Novartis Company Details 58
7.3.2 Novartis Business Overview 58
7.3.3 Novartis Premature Ovarian Failure Cure Introduction 59
7.3.4 Novartis Revenue in Premature Ovarian Failure Cure Business (2017-2022) 60
7.3.5 Novartis Recent Development 60
7.4 Bioscience Institute 60
7.4.1 Bioscience Institute Company Details 60
7.4.2 Bioscience Institute Business Overview 61
7.4.3 Bioscience Institute Premature Ovarian Failure Cure Introduction 61
7.4.4 Bioscience Institute Revenue in Premature Ovarian Failure Cure Business (2017-2022) 62
7.4.5 Bioscience Institute Recent Development 62
7.5 Johns Hopkins Medicine 62
7.5.1 Johns Hopkins Medicine Company Details 62
7.5.2 Johns Hopkins Medicine Business Overview 63
7.5.3 Johns Hopkins Medicine Premature Ovarian Failure Cure Introduction 63
7.5.4 Johns Hopkins Medicine Revenue in Premature Ovarian Failure Cure Business (2017-2022) 64
7.5.5 Johns Hopkins Medicine Recent Development 64
7.6 Mayo Clinic 64
7.6.1 Mayo Clinic Company Details 64
7.6.2 Mayo Clinic Business Overview 65
7.6.3 Mayo Clinic Premature Ovarian Failure Cure Introduction 65
7.6.4 Mayo Clinic Revenue in Premature Ovarian Failure Cure Business (2017-2022) 66
7.6.5 Mayo Clinic Recent Development 66
7.7 Baptist Health 67
7.7.1 Baptist Health Company Details 67
7.7.2 Baptist Health Business Overview 67
7.7.3 Baptist Health Premature Ovarian Failure Cure Introduction 68
7.7.4 Baptist Health Revenue in Premature Ovarian Failure Cure Business (2017-2022) 68
7.7.5 Baptist Health Recent Development 69
7.8 Indira IVF 69
7.8.1 Indira IVF Company Details 69
7.8.2 Indira IVF Business Overview 69
7.8.3 Indira IVF Premature Ovarian Failure Cure Introduction 70
7.8.4 Indira IVF Revenue in Premature Ovarian Failure Cure Business (2017-2022) 71
7.8.5 Indira IVF Recent Development 71
8 RESEARCH FINDINGS AND CONCLUSION 72
9 APPENDIX 74
9.1 Research Methodology 74
9.1.1 Methodology/Research Approach 74
9.1.2 Data Source 77
9.2 Disclaimer 80
9.3 Author Details 80

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630